Lipogems at Joint Preservation Congress in Warsaw

IV Joint Preservation Congress - Warsaw

Current treatments for degenerative diseases are unable to maintain full joint functionality and patients' physical fitness. Due to the predicted continuous increase in these conditions, physicians worldwide are seeking effective alternative treatments. New therapies should aim to reduce patient pain and extend physical activity. The conference features world-renowned experts - physicians and scientists including Prof. Carlo Tremolada - who are leaders in developing and applying new technologies for treating degenerative diseases and related trauma.

Joint Preservation with Lipogems Method

Mesenchymal stem cells facilitate healing from trauma and injuries, and Lipogems® provides a simplified, rapid, and safe system for recovery by delivering these cells naturally through autologous adipose tissue transplantation. Patients with articular cartilage lesions often experience joint pain and reduced functionality, frequently progressing to osteoarthritis - one of the top 10 causes of disability worldwide. Lipogems accelerates the natural tissue regeneration and repair process, enabling conservative treatment of various pathologies including degenerative joint conditions affecting the shoulder, knee, ankle, and hip.

The technology's unique processing method preserves the structural integrity of adipose tissue while maintaining its vascular network and extracellular matrix. This preservation ensures optimal integration and therapeutic efficacy when transplanted. The high concentration of mesenchymal stem cells present in processed adipose tissue, combined with growth factors and cytokines, promotes tissue repair and stimulates the body's natural healing response.